Founders & Management
Siddhesh Angle, PhD
Founder, President &
Chief Executive Officer
Dr. Siddhesh Angle's career in musculoskeletal research & development spans 15 years. Dr. Angle played an integral role in the acquisition of a synthetic biomaterials start-up by Zimmer Biomet. He was then R&D Manager for their Global Biologics business and has successfully commercialized several orthopedic medical devices and combination therapies.
Bruce Cronstein, MD
Co-founder & Chair of the
Scientific Advisory Board
Dr. Bruce Cronstein was the first to discover the anti-inflammatory effects of adenosine and its role in wound healing, maintaining cartilage homeostasis, and treating OA. He is the 2013 recipient of the Lee Howley Prize for Research in Arthritis and holds leadership positions in American College of Rheumatology and NYU School of Medicine.
TEAM
Venkat Perumal, PhD (Drug Development)
Shari Burgess (Clinical Operations)
Shari Burgess (Clinical Operations)
Shari Burgess (Clinical Operations)
Shari Burgess (Clinical Operations)
Shari Burgess (Clinical Operations)
Brandy Craig Druesedow (PR & Marketing)
Shari Burgess (Clinical Operations)
Brandy Craig Druesedow (PR & Marketing)
Robert Dupuit, PhD (Drug CMC)
Jay Stallons, PhD (Drug Toxicology)
Brandy Craig Druesedow (PR & Marketing)
Jay Stallons, PhD (Drug Toxicology)
Jay Stallons, PhD (Drug Toxicology)
Jay Stallons, PhD (Drug Toxicology)
Clinical AdvisorS
Marc C. Hochberg, MD
Marc C. Hochberg, MD
Marc C. Hochberg, MD
Richard Loeser, MD
Marc C. Hochberg, MD
Marc C. Hochberg, MD
Lee Simon, MD
Marc C. Hochberg, MD
Lee Simon, MD
STRATEGIC ADVISORS
Robert E. Farrell, Jr
Kumaresh Soppimath, PhD
Robert E. Farrell, Jr
Christoph Ladel, PhD
Kumaresh Soppimath, PhD
Robert E. Farrell, Jr
Kumaresh Soppimath, PhD
Kumaresh Soppimath, PhD
Kumaresh Soppimath, PhD
Investors & Partners
